Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

YKL-40 protein in osteosarcoma tumor tissue

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Primary antibiotic resistance of Helicobacter pylori strains among adults and children in a tertiary referral centre in Lithuania

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A short history of microbial biofilms and biofilm infections

    Research output: Contribution to journalReviewResearchpeer-review

  3. Biofilms and host response - helpful or harmful

    Research output: Contribution to journalReviewResearchpeer-review

  4. Diagnosis of biofilm infections in cystic fibrosis patients

    Research output: Contribution to journalReviewResearchpeer-review

  1. Prognostic and Clinicopathologic Associations of LAG-3 Expression in Triple-negative Breast Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Collagen Growth Pattern in Human Articular Cartilage of the Knee

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Clinical outcome after surgery on schwannomas in the extremities

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

YKL-40, a cellular glycoprotein isolated from the human osteosarcoma (OS) cell line MG63, is increased in the blood of patients with various types of cancer, and is found as an independent prognostic variable for survival. YKL-40 is also present with variable intensity in the tumor cells of some cancer types, but survival results have been conflicting. The aim of this study was to investigate the tissue expression of YKL-40 and its possible role as a predictive marker in patients with OS. Forty-eight patients were included in the study. Diagnostic biopsies were analyzed by immunohistochemistry; YKL-staining scores as well as CD14 and CD163 scores were determined, and survival data were determined statistically. A universal intense immunostaining for YKL-40 was found in all tumor cells, but tumor cell/stroma ratio varied, and this ratio (%) served as staining score. Using 24% as mean score to divide the material, patients with tumors of high YKL-40 score had a better survival than patients with low score (p = 0.05). YKL-positive macrophages had no influence on the result. Unexpectedly and contrary to some other findings in cancer tissues, this study has shown a correlation between high YKL-40 tumor cell/matrix ratio and longer overall survival in OS.

Original languageEnglish
JournalAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Volume124
Issue number6
Pages (from-to)453-61
Number of pages9
ISSN0903-4641
DOIs
Publication statusPublished - Jun 2016

    Research areas

  • Adolescent, Adult, Aged, Aged, 80 and over, Antigens, CD, Antigens, CD14, Antigens, Differentiation, Myelomonocytic, Biomarkers, Biopsy, Child, Chitinase-3-Like Protein 1, Female, Humans, Immunohistochemistry, Male, Middle Aged, Osteosarcoma, Prognosis, Receptors, Cell Surface, Survival Analysis, Young Adult, Journal Article

ID: 49803198